Stockreport

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of smal [Read more]